• Integrating Blood-Based Biomarkers for Alzheimer’s Risk Assessment

  • Jan 17 2025
  • Length: 27 mins
  • Podcast

Integrating Blood-Based Biomarkers for Alzheimer’s Risk Assessment

Listen for free

View show details

  • Summary

  • In this episode of Results are In by Quest Diagnostics, Amanda Benson is joined by Dr. Michael Racke, Medical Director for Neurology at Quest Diagnostics, to discuss the groundbreaking role blood-based biomarkers play in assessing Alzheimer’s disease risk. Dr. Racke shares his expert insights on how these biomarkers are revolutionizing early risk detection and diagnosis, offering primary care physicians a proactive tool to identify Alzheimer’s before cognitive symptoms appear. From the evolution of Alzheimer's diagnostics to the practical application of plasma-based tests, Dr. Racke explains how integrating these tests into routine health visits can enable earlier interventions and better patient outcomes. He also discusses how blood-based biomarkers, in conjunction with digital cognitive assessments, are improving the sensitivity of Alzheimer’s screenings. This episode is a must-listen for anyone interested in the future of Alzheimer’s diagnostics and the power of early detection in cognitive health.

    Follow Us
    Twitter @QuestDX
    Facebook @QuestDiagnostics
    Instagram @QuestDiagnostics

    LinkedIn @QuestDiagnostics

    Presented by Quest Diagnostics
    www.questdiagnostics.com
    Show More Show Less
Show More Show Less

What listeners say about Integrating Blood-Based Biomarkers for Alzheimer’s Risk Assessment

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available